Learning Attention deficit hyperactivity disorder: management and support Management of attention deficit hyperactivity disorder (ADHD) aims to reduce the severity of symptoms and improve quality of life. This article outlines the pharmacological and non-pharmacological interventions available and how pharmacists can support people with ADHD.…Published: 18 April 2023
Learning Attention deficit hyperactivity disorder: characteristics and diagnosis Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterised by age-inappropriate levels of inattention, hyperactivity and impulsivity. This article outlines how to recognise ADHD and support patients and families following a diagnosis.…Published: 11 April 2023
Learning Autism: identification, management and support Healthcare professionals need a robust knowledge of autism and the challenges faced by autistic individuals and their carers to provide effective support. Pharmacists can ensure medicines are used appropriately and make reasonable adjustments to provide equitable access to services.…Published: 21 March 2023
Learning Test yourself: the 2022 CPD and Learning quiz Take our end-of-year quiz to test your learning and reflect on areas that you may need to focus on ahead of revalidation.…Published: 20 December 2022
Learning Management of Parkinson’s disease An overview of the symptomatic management of Parkinson's disease.…Published: 10 June 2022
Learning Epilepsy: management An overview of commonly used anti-seizure medicines as well as guidance on their initiation, adding on and withdrawal.…Published: 3 May 2022
Learning Epilepsy: symptoms and diagnosis An overview of epilepsy, including seizure types, associated risks and diagnosis.…Published: 27 April 2022
Learning Multiple sclerosis: disease-modifying therapies An overview of the available evidence for each disease-modifying therapy for multiple sclerosis, when they are indicated, as well as each stage of patient care.…Published: 22 March 2022
Learning Case study: treatment-resistant schizophrenia An examination of how a patient with schizophrenia, who is transferred from a mental health hospital to the community, is treated with clozapine effectively.…Published: 18 January 2022
Learning Valproate use in women: minimising the risks It is necessary that pharmacists and pharmacy teams ensure the safe and appropriate prescribing of valproate in line with the current Medicines and Healthcare products Regulatory Agency guidance.…Published: 15 December 2020 Supported content
